Adaptimmune Therapeutics PLC (24)

Browse by Contract Category

Contracts

Rent Security Deposit Deed dated August 20, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc... (Filed With SEC on August 20, 2021)
Deed of Variation dated August 20, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited and Adaptimmune Limited relating to a lease of 39 Innovation... (Filed With SEC on August 20, 2021)
Agreement dated August 13, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc relating to 39... (Filed With SEC on August 13, 2021)
Employment Agreement dated as of December 16, 2020 by and between Adaptimmune, LLC and Elliot Norry (Filed With SEC on December 16, 2020)
Collaboration and License Agreement, dated January 13, 2020, by and between Universal Cells, Inc. and Adaptimmune Limited (Filed With SEC on February 27, 2020)
Deed of Variation dated August 13, 2021, between MEPC Milton Park No 1 Limited and MEPC Milton Park No. 2 Limited, Adaptimmune Limited and Adaptimmune Therapeutics plc relating to... (Filed With SEC on August 13, 2021)
Description of the Registrants Securities (Filed With SEC on February 25, 2021)
Underwriting Agreement, dated June 1, 2020, by and among Adaptimmune Therapeutics plc, Cowen and Company, LLC and SVB Leerink LLC, as representative of the several Underwriters... (Filed With SEC on June 2, 2020)
Description of the Registrants Securities (Filed With SEC on February 27, 2020)
Variation Agreement dated as of February 17, 2020 by and between Adaptimmune, LLC and La Fosse Associates Limited (Filed With SEC on February 18, 2020)
Variation Agreement dated as of February 17, 2020 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC (Filed With SEC on February 18, 2020)
Service Agreement dated as of February 17, 2020 by and between Adaptimmune Limited and Gavin Wood (Filed With SEC on February 18, 2020)
Underwriting Agreement, dated January 22, 2020, by and between Adaptimmune Therapeutics plc and Cowen and Company, LLC, as representative of the several Underwriters named therein (Filed With SEC on January 22, 2020)
Senior Vice President Severance Policy dated December 4, 2019 (Filed With SEC on January 13, 2020)
Employment Agreement dated as of January 13, 2020 by and between Adaptimmune, LLC and Elliot Norry (Filed With SEC on January 13, 2020)
Agreement dated as of September 30, 2019 by and between La Fosse Associates Limited, GAR-1 Business Advisory Services and Adaptimmune, LLC (Filed With SEC on November 6, 2019)
Agreement dated as of September 30, 2019 by and between La Fosse Associates Limited and Adaptimmune, LLC (Filed With SEC on November 6, 2019)
Collaboration Agreement dated as of August 26, 2019 by and among Adaptimmune Limited and Noile-Immune Biotech, Inc (Filed With SEC on August 27, 2019)
Collaboration Agreement dated May 14, 2019 between Adaptimmune Limited and AIS Operating Co., Inc., f/k/a Alpine Immune Sciences, Inc (Filed With SEC on August 1, 2019)
Employment Agreement dated as of August 1, 2019 by and between Adaptimmune, LLC and John Lunger (Filed With SEC on August 1, 2019)
James Noble Letter Agreement dated June 26, 2019 (Filed With SEC on June 27, 2019)
James Noble Letter of Appointment dated June 26, 2019 (Filed With SEC on June 27, 2019)
James Noble Variation Agreement dated June 26, 2019 (Filed With SEC on June 27, 2019)
Employment Agreement dated as of June 26, 2019 by and between Adaptimmune, LLC and Adrian Rawcliffe (Filed With SEC on June 27, 2019)